An attempt to calculate in silico disintegration time of tablets containing mefenamic acid, a low water-soluble drug.

Based on a Quality by Design (QbD) approach, it is important to follow International Conference on Harmonization (ICH) guidance Q8 (R2) recommendations to explore the design space. The application of an experimental design is, however, not sufficient because of the fact that it is necessary to take into account the effects of percolation theory. For this purpose, an adequate software needs to be applied, capable of detecting percolation thresholds as a function of the distribution of the functional powder particles. Formulation-computer aided design (F-CAD), originally designed to calculate in silico the drug dissolution profiles of a tablet formulation is, for example, a suitable software for this purpose. The study shows that F-CAD can calculate a good estimate of the disintegration time of a tablet formulation consisting of mefenamic acid. More important, F-CAD is capable of replacing expensive laboratory work by performing in silico experiments for the exploration of the formulation design space according to ICH guidance Q8 (R2). As a consequence, a similar workflow existing as best practice in the automotive and aircraft industry can be adopted by the pharmaceutical industry: The drug delivery vehicle can be first fully designed and tested in silico, which will improve the quality of the marketed formulation and save time and money.

[1]  J. Fell,et al.  The tensile strength of lactose tablets , 1968, The Journal of pharmacy and pharmacology.

[2]  Etienne Krausbauer,et al.  Contributions to a science based expert system for solid dosage form design , 2009 .

[3]  H. Leuenberger,et al.  Percolation theory — a novel approach to solid dosage form design , 1987 .

[4]  Hans Leuenberger,et al.  Rational estimation of the optimum amount of non-fibrous disintegrant applying percolation theory for binary fast disintegrating formulation. , 2008, Journal of pharmaceutical sciences.

[5]  H. Leuenberger,et al.  Percolation Theory and the Role of Maize Starch as a Disintegrant for a Low Water-Soluble Drug , 2007, Pharmaceutical development and technology.

[6]  R. Newnham,et al.  Electrical Resistivity of Composites , 1990 .

[7]  H. Leuenberger,et al.  Influence of Loading Volume of Mefenamic Acid on Granules and Tablet Characteristics Using a Compaction Simulator , 2008, Pharmaceutical development and technology.

[8]  Y. Seta,et al.  Measurement of agitation force in dissolution test and mechanical destructive force in disintegration test. , 2003, International journal of pharmaceutics.

[9]  Hans Leuenberger,et al.  The application of percolation theory in powder technology , 1999 .

[10]  Harvey Scher,et al.  Critical Density in Percolation Processes , 1970 .

[11]  J. Yliruusi,et al.  Effect of amount of granulation liquid on total pore volume and pore size distribution of lactose, glucose and mannitol granules , 1994 .

[12]  Go Kimura,et al.  Design of pharmaceutical tablet formulation for a low water soluble drug : search for the critical concentration of starch based disintegrant applying percolation theory and F-CAD (Formulation-Computer Aided Design) , 2012 .

[13]  S. Redner,et al.  Introduction To Percolation Theory , 2018 .

[14]  M. J. Powell.  Site percolation in randomly packed spheres , 1979 .

[15]  L. M. Middleman,et al.  Electron transport processes in conductor‐filled polymers , 1983 .

[16]  Hans Leuenberger,et al.  Pharmaceutical powder technology — from art to science: the challenge of the FDA's Process Analytical Technology initiative , 2005 .

[17]  Michael N. Leuenberger,et al.  Implementing virtual R&D reality in industry: In­silico design and testing of solid dosage forms , 2009 .

[18]  Hans Leuenberger,et al.  Use of percolation theory to interpret water uptake, disintegration time and intrinsic dissolution rate of tablets consisting of binary mixtures , 1994 .